There’s endless talk about precision medicine. But what’s really moving the needle — and what’s limiting its potential— now and in the future?
Those were the questions that brought together a handful of high-profile names in biopharma for a panel discussion on Friday at the final day of the World Economic Forum’s annual meeting in the Swiss resort town of Davos.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
pricision medicine is promising goal of human health and medical sciences .there are so much work to do for prcision mdecine and a long way to go but is worth doing !
When will we do the most basic things to protect patient and public health: like prescreening and pretesting people for tolerance or reactivity to medical and dental device materials? Like FDA recommends for hair color?
Without Precision Devices and Precision Dentistry, we will never have Precision Medicine succeed. Its pitfall is lack of attention to precaution, prevention, and public health.